Page last updated: 2024-10-18

gamma-butyrobetaine and Disease Exacerbation

gamma-butyrobetaine has been researched along with Disease Exacerbation in 1 studies

4-(trimethylammonio)butanoate : An amino-acid betaine gamma-aminobutyric acid zwitterion in which all of the hydrogens attached to the nitrogen are replaced by methyl groups.

Research Excerpts

ExcerptRelevanceReference
"The elevation of the levels of l-carnitine and its fatty acid esters, acylcarnitines, in tissue or plasma has been linked to the development of atherosclerosis."7.81Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis. ( Cirule, H; Dambrova, M; Grinberga, S; Kuka, J; Liepinsh, E; Makarova, E; Makrecka-Kuka, M; Sevostjanovs, E; Vilskersts, R; Volska, K, 2015)
"The elevation of the levels of l-carnitine and its fatty acid esters, acylcarnitines, in tissue or plasma has been linked to the development of atherosclerosis."3.81Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis. ( Cirule, H; Dambrova, M; Grinberga, S; Kuka, J; Liepinsh, E; Makarova, E; Makrecka-Kuka, M; Sevostjanovs, E; Vilskersts, R; Volska, K, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vilskersts, R1
Kuka, J1
Liepinsh, E1
Makrecka-Kuka, M1
Volska, K1
Makarova, E1
Sevostjanovs, E1
Cirule, H1
Grinberga, S1
Dambrova, M1

Other Studies

1 other study available for gamma-butyrobetaine and Disease Exacerbation

ArticleYear
Methyl-γ-butyrobetaine decreases levels of acylcarnitines and attenuates the development of atherosclerosis.
    Vascular pharmacology, 2015, Volume: 72

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Betaine; Carnitine; Disease Progression; Female;

2015